Literature DB >> 17085293

The effect of erythrodiol-3-acetate on the expressions of matrix metalloproteinase-1 and type-1 procollagen caused by ultraviolet irradiated cultured primary old aged human skin fibroblasts.

H-I Moon1, J Lee, J H Chung.   

Abstract

Methanol and aqueous extracts of Styrax japonica used traditionally for the treatments of skin elastic materials were screened in vitro for the matrix metalloproteinase (MMP)-1 inhibitor actions. The methylene chloride soluble fraction of methanol extract from the stems of S. japonica showed significant MMP-1 inhibition in primary old aged human skin fibroblasts caused by ultraviolet (UV) irradiation. Main triterpenoids were isolated by repeated column chromatography. Among them, the triterpenoid erythrodiol-3-acetate reduced the expression of MMP-1 and induced the expression of type-1 procollagen at the protein levels in a dose-dependent manner caused by UV irradiated cultured old aged human skin fibroblasts. Taken together, our results suggest that erythrodiol-3-acetate plays an important role in the skin aging process caused by UV irradiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17085293     DOI: 10.1016/j.phymed.2005.10.001

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  3 in total

1.  Inhibitory Effects of Terminalia catappa on UVB-Induced Photodamage in Fibroblast Cell Line.

Authors:  Kuo-Ching Wen; I-Chen Shih; Jhe-Cyuan Hu; Sue-Tsai Liao; Tsung-Wei Su; Hsiu-Mei Chiang
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-14       Impact factor: 2.629

2.  Skin ageing: natural weapons and strategies.

Authors:  Ivana Binic; Viktor Lazarevic; Milanka Ljubenovic; Jelena Mojsa; Dusan Sokolovic
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-29       Impact factor: 2.629

3.  Ixora parviflora Protects against UVB-Induced Photoaging by Inhibiting the Expression of MMPs, MAP Kinases, and COX-2 and by Promoting Type I Procollagen Synthesis.

Authors:  Kuo-Ching Wen; Pei-Ching Fan; Shang-Yuan Tsai; I-Chen Shih; Hsiu-Mei Chiang
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-01       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.